Phone 02 9553 0006
Phone 02 9553 0006
TV Stories, Podcasts & Articles
Severe asthma in 2026. An approach to chronic cough. 30 July 2026
A practical update covering two key areas in respiratory health. We’ll explore how severe asthma management is evolving in 2026, highlighting what clinicians need to let go of, what to adopt and how to optimise patient care. We’ll also take an evidence‑based look at assessing and managing chronic cough in general practice settings. Additionally, a patient will join us live to speak about their own case and lived experience, offering real‑world perspective to complement the clinical content. Part of Shire CPD series for GPs Presented by: Associate Professor Gregory Katsoulotos, NAC Guidelines Committee member and Respiratory, Sleep and Allergy Physician Objectives of this talk: management of severe asthma and chronic cough assessment and management of complex presentations new and available therapies for severe asthma Once viewed you can self-report this as EA CPD activity hours with your governing body.
Price of life-changing medicines being slashed within days | 7NEWS | 28/06/2026
Ten new life-changing medications will be added to the Pharmaceutical Benefits Scheme from next week, reducing costs from thousands of dollars to as little as seven dollars per prescription. The subsidised drugs include breakthrough treatments for severe asthma, type 1 diabetes, various cancers, chronic pain, severe allergies and rare conditions affecting thousands of Australians. The PBS now subsidises almost 1,000 drugs, helping 23 million patients at a cost of approximately $20 billion annually, though the scheme faces potential threats from international pharmaceutical pricing pressures.
A new sleep testing device using AI: A/Prof Greg Katsoulotos
Sky TV News Interview, 14-08-2023